The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Metastatic Castrate-Sensitive Prostate Cancer Patients Treated with Abiraterone Acetate by Caio Vinícius Suartz, Marie-Laurence Roy, Paul Toren

Get full text

High infiltration of CD209+ dendritic cells and CD163+ macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes by Oscar Eduardo Molina, Oscar Eduardo Molina, Hélène LaRue, Hélène LaRue, David Simonyan, Hélène Hovington, Hélène Hovington, Bernard Têtu, Bernard Têtu, Vincent Fradet, Vincent Fradet, Vincent Fradet, Louis Lacombe, Louis Lacombe, Louis Lacombe, Paul Toren, Paul Toren, Paul Toren, Alain Bergeron, Alain Bergeron, Alain Bergeron, Yves Fradet, Yves Fradet, Yves Fradet

Get full text

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment by Marjorie Besançon, Typhaine Gris, France-Hélène Joncas, Valérie Picard, Alain Bergeron, Yves Fradet, Paul Toren

Get full text

Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs by Clovis Boibessot, France-Hélène Joncas, Aerin Park, Zohra Berrehail, Jean-François Pelletier, Typhaine Gris, Alain Bergeron, Paul Toren

Get full text

Follicle Stimulating Hormone Levels During Androgen Deprivation Therapy Are Not Associated With Survival or Development of Castration-Resistant Prostate Cancer by Kaleem Atchia, France-Hélène Joncas, Lily Summers Trasiewicz, Wei Phin Tan, Keyue Ding, Brant A. Inman, Paul Toren

Get full text

Influence of novel CYP2C‐haplotype on proton pump inhibitor pharmacokinetics in children by Kathryn E. Kyler, Andrea Gaedigk, Susan Abdel‐Rahman, Vincent S. Staggs, Robin E. Pearce, Paul Toren, J. Steven Leeder, Valentina Shakhnovich

Get full text

Discordance between testosterone measurement methods in castrated prostate cancer patients by Mélanie Rouleau, Francis Lemire, Michel Déry, Benoît Thériault, Gabriel Dubois, Yves Fradet, Paul Toren, Chantal Guillemette, Louis Lacombe, Laurence Klotz, Fred Saad, Dominique Guérette, Frédéric Pouliot

Get full text

Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype by Clovis Boibessot, Oscar Molina, Gabriel Lachance, Christophe Tav, Audrey Champagne, Bertrand Neveu, Jean‐François Pelletier, Frédéric Pouliot, Vincent Fradet, Steve Bilodeau, Yves Fradet, Alain Bergeron, Paul Toren

Get full text

Effects of omega‐3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double‐blind placebo‐controlled randomized trial by Josée Savard, Hanane Moussa, Jean‐François Pelletier, Pierre Julien, Louis Lacombe, Rabi Tiguert, Yves Caumartin, Thierry Dujardin, Paul Toren, Frédéric Pouliot, Michele Lodde, Yves Fradet, Karine Robitaille, Vincent Fradet

Get full text

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation by Karine Robitaille, Marie-Hélène Guertin, Afshin Jamshidi, Hui Wen Xu, Hélène Hovington, Jean-François Pelletier, Lisanne Beaudoin, Nikunj Gevariya, Louis Lacombe, Rabi Tiguert, Yves Caumartin, Thierry Dujardin, Paul Toren, Michele Lodde, Étienne Racine, Dominique Trudel, Martine Perigny, Thierry Duchesne, Josée Savard, Pierre Julien, Yves Fradet, Vincent Fradet

Get full text